Perioperative Atezolizumab Treatment Does Not Improve EFS in TNBC
T-DXd Preserves QOL, Neurological Function in HER2+ Metastatic Breast Cancer Irrespective of Brain Metastases
Neoadjuvant Niraparib Plus Dostarlimab Generates pCRs in BRCA+ ER+/HER2– Breast Cancer
Camrelizumab/Chemo Could Represent New Neoadjuvant Option in Early or Locally Advanced TNBC
